Arthi Thirumalai,Stephanie T Page
Arthi Thirumalai
Purpose of review: Rates of unintended pregnancy have remained relatively stagnant for many years, despite a broad array of female contraceptive options. Recent restrictions on access to abortion in some countries have in...
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease [0.03%]
高密度脂蛋白系统的新认识及其在动脉粥样硬化性心血管疾病防治中的作用展望
Nick S R Lan,Gerald F Watts
Nick S R Lan
Purpose of review: The causal role of high-density lipoprotein (HDL) in atherosclerotic cardiovascular disease (CVD) remains debated. Considering recent evidence, the purpose of this review is to a provide a focused updat...
Gonzalo J Acosta,Naykky Singh Ospina,Juan P Brito
Gonzalo J Acosta
Purpose of review: To analyze the evolving epidemiologic trends in thyroid disease, focusing on risk factors, underlying drivers of these changes, and their implications on clinical practice and research priorities. ...
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease [0.03%]
TSHR-IGF-IR复合体驱动甲状腺眼病中眼眶成纤维细胞的异常行为
Terry J Smith
Terry J Smith
Purpose of review: Evolving understanding of thyroid eye disease (TED) has led to rapidly advancing therapeutic options. Most new treatments under development or recently available to patients are predicated on insights i...
Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name? [0.03%]
冠状动脉无事件或家族性高胆固醇耐受性：名字背后的意义是什么？
Seyed Saeed Tamehri Zadeh,Dick C Chan,Pedro Mata et al.
Seyed Saeed Tamehri Zadeh et al.
Purpose of review: Familial hypercholesterolemia (FH) is an autosomal semi-dominant condition, characterized by excessive circulating low-density lipoprotein cholesterol (LDL-C) from birth that substantially accelerates t...
Advances in assessment and treatment of bone, mineral and parathyroid disorders [0.03%]
骨、矿物质及甲状旁腺紊乱的评估和治疗进展
Samuel D Vasikaran
Samuel D Vasikaran
Eugene McCloskey,Andre T H Tan,Marian Schini
Eugene McCloskey
Purpose of review: The assessment of fracture risk is playing an ever-increasing role in osteoporosis clinical management and informing international guidelines for osteoporosis. FRAX, a fracture risk calculator that prov...
Insight into the potential of bone turnover biomarkers: integration in the management of osteoporosis and chronic kidney disease-associated osteoporosis [0.03%]
骨转换生物标志物潜力的洞察：在骨质疏松症和慢性肾脏病相关性骨质疏松症管理中的整合
Pauline Brouwers,Antoine Bouquegneau,Etienne Cavalier
Pauline Brouwers
Purpose of review: Disturbances in mineral and bone metabolism occurring in osteoporosis and chronic kidney disease-associated osteoporosis place patients at high risk of fracture making these conditions a major public he...
Cherie Chiang
Cherie Chiang
Purpose of review: Since the release of the 2022 Second International Workshop Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines, updates and advances are now available in the cause, complic...
The use of anabolic agents in the treatment of osteoporosis: a clinical update [0.03%]
雄激素类药物治疗骨质疏松症的临床应用进展
Charles A Inderjeeth,Diren C Inderjeeth
Charles A Inderjeeth
Purpose of review: Anabolic therapies have revolutionized the management of patients with osteoporosis, especially those at very high fracture risk. The current review offers valuable insights into the latest evidence and...